Edgewise Therapeutics IPO

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.

Register for Details

For more details on financing and valuation for Edgewise Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Edgewise Therapeutics's ticker symbol?


What is Edgewise Therapeutics's stock price?

6.17 as of 9/19/23

Learn more about Edgewise Therapeutics

Forge green plus iconForge green minus icon

What is Edgewise Therapeutics funding to date?

Edgewise Therapeutics has raised $65.5MM to date.
Forge green plus iconForge green minus icon

When was Edgewise Therapeutics founded?

Edgewise Therapeutics was founded in 2017.
Updated on: Jun 12, 2022